Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001522780-25-000007

Director sold 25,000 shares at $30.00 ($750,000)

  • Director acquired 25,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kaye Edward M. MD · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-08 Exercise or conversion : show line 1 in the form 10b5-1 +25,000 $0.60 $15,000 74,124 D
2025-10-08 Sale : show line 2 in the form 10b5-1 −25,000 $30.00 $750,000 49,124 D
Open-market sales · 25,000 sh · avg $30.00 · $750,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-08 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −25,000 542,801 D
Loading xslF345X05/form4-10102025_081021.xml…